Skip to main content

Table 3 Neonatal Outcomes

From: A randomized trial comparing the pharmacology of magnesium sulfate when used to treat severe preeclampsia with serial intravenous boluses versus a continuous intravenous infusion

 

Serial IV Bolus

Continuous Infusion

Mothers enrolled

n = 100

n = 100

Enrolled postpartum

0

2

Discharged prior to delivery

0

6

Twin Infants

6

2

Missing data

1

2

Newborns evaluated

n = 105

n = 92

Live Birth- N (%)

105 (100%)

91 (98.9%)

Stillbirth- N (%)

0

1 (1.1%)

Intubated at delivery - N (%)

6 (5.7%)

6 (6.5%)

Mechanical Ventilation - N (%)

3 (2.8%)

6 (6.5%)

Bradycardia < 110/min - N (%)

2 (1.9%)

4 (4.3%)

Special Care Nursery - N (%)

25 (23.8%)

26 (28.2%)

Neonatal Deaths - N (%)

2 (1.9%)

3 (3.2%)

 Prematurity

0

1

 Unknown

2

2